biotechnology
CytoDyn’s Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab (CYDY)
VANCOUVER, Washington, March 08, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing
Read more
Reflect Scientific Ends 2020 Fourth Quarter with Increased Year Over Year Sales (RSCF)
OREM, Utah, Feb. 23, 2021 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services
Read more
CytoDyn in Discussions with U.S. FDA, MHRA and Health Canada After Unblinding its CD12 Trial Data for Severe-to-Critically Ill COVID-19 Patients (CYDY)
CytoDyn expects to release CD12 data and complete discussions with various regulatory agencies within 2 to 3 weeks VANCOUVER, Washington,
Read more
Seer’s MV Technologies Receives and Completes Multiple New Biogas System Contracts for Leading Industrial Biotechnology Companies
MV Technologies completes installation of H2S removal systems for innovative California dairy biogas projects as well as the cardboard and
Read more
BioLargo Revenue Continues Breaking Records as Water Technologies Ready for Commercialization
Technology Portfolio Expanding WESTMINSTER, CA / ACCESSWIRE / November 16, 2020 / BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a
Read more
Generex Biotechnology Announces Shareholder Conference Call on Wednesday August 26th, 2020 at 9:30 AM to Provide Details on Impending Corporate Initiatives
Telemedicine & Remote Patient Monitoring Partnership Arizona MSO/HMO update AltuCell acquisition update MIRAMAR, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) —
Read more
Generex Biotechnology Announces That FDA has Accepted the Pre-IND Briefing Package for the Company’s Ii-Key-SARS-CoV-2 Vaccine and Will Provide a Written Response by August 24, 2020
MIRAMAR, Fla., July 27, 2020 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the FDA has
Read more
Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Trial
Prospective, randomized, single‑blinded, multi‑center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to
Read more
Featured Interview: President Damon Mintz of Innovest Global, Inc. (OTCPink: IVST)
President Damon Mintz of Innovest Global, Inc., talks about being a diversified company, with quality holdings in multiple industries, and plans for growing shareholder value in 2019.
Read more
SANUWAVE Health, Inc., CEO Kevin Richardson Returns to Uptick Newswire’s “Stock Day” with Everett Jolly to Discuss Recent Accomplishments
Phoenix, AZ (Uptick Newswire – February 21, 2018) – SANUWAVE Health, Inc. (OTCQB: SNWV) (“the Company”), today announced CEO Kevin Richardson’s
Read more
Pressure BioSciences, Inc. and ISS, Inc. Announce Two-Year Worldwide Co-Marketing and Distribution Agreement
ISS High Pressure Optical Cell Integrated with PBI Automated High Pressure Instrument: Combination Results in Unique Analytical System with Potential to Significantly
Read more